Isoenzyme selective phosphodiesterase inhibitors: potential clinical uses.
- 1 January 1993
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 35 (1) , 1-7
- https://doi.org/10.1111/j.1365-2125.1993.tb05662.x
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.Thorax, 1991
- Cyclic nucleotide phosphodiesterases: Pharmacology, biochemistry and functionPharmacology & Therapeutics, 1991
- Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitorsTrends in Pharmacological Sciences, 1990
- High pressure liquid chromatography of cyclic nucleotide phosphodiesterase from purified human T-lymphocytesBiochemical and Biophysical Research Communications, 1989
- A double‐blind dose‐finding study of rolipram in patients with major depressive disorderHuman Psychopharmacology: Clinical and Experimental, 1988
- A novel site of action of a high affinity A1 adenosine receptor antagonistBiochemical and Biophysical Research Communications, 1988
- G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALSAnnual Review of Biochemistry, 1987
- Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: A multicenter studyJournal of the American College of Cardiology, 1987
- Pharmacological studies with SK&F 94120, a novel positive inotropic agent with vasodilator activityJournal of Pharmacy and Pharmacology, 1986
- Effects of rolipram, a novel antidepressant, on monoamine metabolism in rat brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985